13F HOLDINGS REPORT
TANG CAPITAL MANAGEMENT LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001214659-23-002405
Total Value
$688.3M
Positions
89
Other Managers
1
Confidential Omitted
No
Holdings (89)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ANAPTYSBIO INC | ANABV | 2,628,678 | $81.5M | 11.84% |
| 2 | ALTIMMUNE INC | ALT | 2,700,450 | $44.4M | 6.45% |
| 3 | BLUEBIRD BIO INC | 09609G100 | 4,635,528 | $32.1M | 4.66% |
| 4 | TARSUS PHARMACEUTICALS INC | TARS | 2,001,585 | $29.3M | 4.26% |
| 5 | BIOATLA INC | BCAB | 3,124,076 | $25.8M | 3.74% |
| 6 | ALNYLAM PHARMACEUTICALS INC | ALNY | 105,000 | $25.0M | 3.63% |
| 7 | AXSOME THERAPEUTICS INC | AXSM | 320,000 | $24.7M | 3.59% |
| 8 | IMMUNOCORE HLDGS PLC | IMCR | 405,600 | $23.1M | 3.36% |
| 9 | MIRUM PHARMACEUTICALS INC | MIRM | 1,120,000 | $21.8M | 3.17% |
| 10 | KALVISTA PHARMACEUTICALS INC | KALV | 3,196,446 | $21.6M | 3.14% |
| 11 | VIRIDIAN THERAPEUTICS INC | VRDN | 692,925 | $20.2M | 2.94% |
| 12 | BEIGENE LTD | BEIGF | 85,000 | $18.7M | 2.72% |
| 13 | BIOCRYST PHARMACEUTICALS INC | BCRX | 1,450,000 | $16.6M | 2.42% |
| 14 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 281,200 | $15.5M | 2.25% |
| 15 | VAXCYTE INC | PCVX | 300,000 | $14.4M | 2.09% |
| 16 | MODERNA INC | MRNA | 80,000 | $14.4M | 2.09% |
| 17 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 240,000 | $12.7M | 1.85% |
| 18 | ASTRAZENECA PLC | AZN | 170,000 | $11.5M | 1.67% |
| 19 | NKARTA INC | NKTX | 1,870,000 | $11.2M | 1.63% |
| 20 | HERON THERAPEUTICS INC | HRTX | 3,755,934 | $9.4M | 1.36% |
| 21 | ENANTA PHARMACEUTICALS INC | ENTA | 200,000 | $9.3M | 1.35% |
| 22 | KINIKSA PHARMACEUTICALS LTD | KNSA | 600,000 | $9.0M | 1.31% |
| 23 | ALBIREO PHARMA INC | 01345P106 | 411,968 | $8.9M | 1.29% |
| 24 | BIO RAD LABS INC | 090572207 | 21,000 | $8.8M | 1.28% |
| 25 | CULLINAN ONCOLOGY INC | CGEM | 809,231 | $8.5M | 1.24% |
| 26 | IONIS PHARMACEUTICALS INC | IONS | 200,000 | $7.6M | 1.10% |
| 27 | LILLY ELI & CO | LLY | 20,000 | $7.3M | 1.06% |
| 28 | THIRD HARMONIC BIO INC | 88427A107 | 1,700,000 | $7.3M | 1.06% |
| 29 | CONCERT PHARMACEUTICALS INC | 206022105 | 1,150,000 | $6.7M | 0.98% |
| 30 | IMMUNOGEN INC | 45253H101 | 1,274,853 | $6.3M | 0.92% |
| 31 | EVOLUS INC | EOLS | 809,488 | $6.1M | 0.88% |
| 32 | CYTOMX THERAPEUTICS INC | CTMX | 3,510,445 | $5.6M | 0.82% |
| 33 | ADICET BIO INC | ACET | 600,000 | $5.4M | 0.78% |
| 34 | GENFIT S A | 372279109 | 1,197,522 | $5.3M | 0.76% |
| 35 | GALAPAGOS NV | GLPGF | 114,950 | $5.1M | 0.74% |
| 36 | CYTOKINETICS INC | CYTK | 110,000 | $5.0M | 0.73% |
| 37 | PYXIS ONCOLOGY INC | PYXS | 3,470,700 | $4.7M | 0.68% |
| 38 | BIONTECH SE | BNTX | 30,000 | $4.5M | 0.65% |
| 39 | ASCENDIS PHARMA A/S | ASND | 36,090 | $4.4M | 0.64% |
| 40 | ALIBABA GROUP HLDG LTD | BBAAY | 50,000 | $4.4M | 0.64% |
| 41 | ITEOS THERAPEUTICS INC | 46565G104 | 216,700 | $4.2M | 0.61% |
| 42 | HEALTH SCIENCES ACQ CORP 2 | G4411D109 | 392,500 | $3.9M | 0.57% |
| 43 | ALLAKOS INC | 01671P100 | 447,967 | $3.8M | 0.55% |
| 44 | BEAM THERAPEUTICS INC | BEAM | 95,000 | $3.7M | 0.54% |
| 45 | AMYLYX PHARMACEUTICALS INC | AMLX | 100,000 | $3.7M | 0.54% |
| 46 | GRAPHITE BIO INC | 38870X104 | 1,100,000 | $3.7M | 0.53% |
| 47 | ARS PHARMACEUTICALS INC | SPRY | 409,463 | $3.5M | 0.51% |
| 48 | EAGLE PHARMACEUTICALS INC | 269796108 | 118,857 | $3.5M | 0.50% |
| 49 | INSMED INC | INSM | 166,203 | $3.3M | 0.48% |
| 50 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 300,000 | $3.2M | 0.46% |
| 51 | ZYMEWORKS DEL INC | ZYME | 400,000 | $3.1M | 0.46% |
| 52 | ARCUS BIOSCIENCES INC | RCUS | 147,920 | $3.1M | 0.44% |
| 53 | LEGEND BIOTECH CORP | LEGN | 60,000 | $3.0M | 0.44% |
| 54 | TCR2 THERAPEUTICS INC | 87808K106 | 2,738,947 | $2.7M | 0.40% |
| 55 | MIRATI THERAPEUTICS INC | 60468T105 | 60,000 | $2.7M | 0.39% |
| 56 | ALIGOS THERAPEUTICS INC | ALGS | 2,816,391 | $2.7M | 0.39% |
| 57 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 245,714 | $2.6M | 0.37% |
| 58 | 2SEVENTY BIO INC | 901384107 | 250,000 | $2.3M | 0.34% |
| 59 | BIOHAVEN LTD | BHVN | 140,000 | $1.9M | 0.28% |
| 60 | ASLAN PHARMACEUTICALS LTD | 04522R101 | 5,364,925 | $1.9M | 0.28% |
| 61 | METACRINE INC | 59101E103 | 4,250,000 | $1.9M | 0.28% |
| 62 | ALDEYRA THERAPEUTICS INC | ALDX | 272,293 | $1.9M | 0.28% |
| 63 | CTI BIOPHARMA CORP | 12648L601 | 300,000 | $1.8M | 0.26% |
| 64 | TONIX PHARMACEUTICALS HLDG C | TNXP | 4,500,419 | $1.8M | 0.25% |
| 65 | BLUEPRINT MEDICINES CORP | 09627Y109 | 40,000 | $1.8M | 0.25% |
| 66 | ATHIRA PHARMA INC | 04746L104 | 485,234 | $1.5M | 0.22% |
| 67 | ARVINAS INC | ARVN | 30,000 | $1.0M | 0.15% |
| 68 | CELLDEX THERAPEUTICS INC NEW | CLDX | 21,192 | $944,527 | 0.14% |
| 69 | COHERUS BIOSCIENCES INC | CHRS | 115,900 | $917,928 | 0.13% |
| 70 | SIO GENE THERAPIES INC | 829399104 | 2,000,000 | $870,000 | 0.13% |
| 71 | AURINIA PHARMACEUTICALS INC | AUPH | 200,000 | $864,000 | 0.13% |
| 72 | TSCAN THERAPEUTICS INC | TCRX | 514,655 | $797,715 | 0.12% |
| 73 | OLEMA PHARMACEUTICALS INC | OLMA | 318,926 | $781,369 | 0.11% |
| 74 | ORCHARD THERAPEUTICS PLC | 68570P101 | 2,000,000 | $742,000 | 0.11% |
| 75 | BOLT BIOTHERAPEUTICS INC | BOLT | 400,000 | $520,000 | 0.08% |
| 76 | ELEVATION ONCOLOGY INC | 28623U101 | 479,854 | $455,861 | 0.07% |
| 77 | ACELRX PHARMACEUTICALS INC | TLPH | 195,000 | $440,700 | 0.06% |
| 78 | CRISPR THERAPEUTICS AG | CRSP | 10,000 | $406,500 | 0.06% |
| 79 | NEKTAR THERAPEUTICS | NKTR | 164,190 | $371,069 | 0.05% |
| 80 | SURFACE ONCOLOGY INC | 86877M209 | 429,647 | $352,311 | 0.05% |
| 81 | RELMADA THERAPEUTICS INC | RLMD | 100,000 | $349,000 | 0.05% |
| 82 | ATYR PHARMA INC | ATYR | 123,430 | $270,312 | 0.04% |
| 83 | GOSSAMER BIO INC | GOSS | 100,000 | $217,000 | 0.03% |
| 84 | MOLECULAR PARTNERS AG | MOLN | 22,000 | $144,100 | 0.02% |
| 85 | VINCERX PHARMA INC | VNCE | 101,762 | $103,797 | 0.02% |
| 86 | REVIVA PHARMACEUTCLS HLDGS I | 76152G100 | 24,125 | $102,531 | 0.01% |
| 87 | LIANBIO | LIANY | 59,600 | $97,744 | 0.01% |
| 88 | RENEO PHARMACEUTICALS INC | 75974E103 | 30,587 | $71,268 | 0.01% |
| 89 | PARDES BIOSCIENCES INC | 69945Q105 | 33,748 | $57,034 | 0.01% |